Submission Details
| 510(k) Number | K221986 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 06, 2022 |
| Decision Date | October 18, 2022 |
| Days to Decision | 104 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K221986 is an FDA 510(k) clearance for the XO Score LP Percutaneous Transluminal Angioplasty Scoring Catheter, XO Score LP Catheter, a Catheter, Percutaneous, Cutting/scoring (Class II — Special Controls, product code PNO), submitted by Transit Scientific, LLC (Salt Lake City, US). The FDA issued a Cleared decision on October 18, 2022, 104 days after receiving the submission on July 6, 2022. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1250.
| 510(k) Number | K221986 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 06, 2022 |
| Decision Date | October 18, 2022 |
| Days to Decision | 104 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | PNO — Catheter, Percutaneous, Cutting/scoring |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1250 |
| Definition | To Reduce Vascular Stenosis By Dilatation And Apposition Of The Cutting/scoring Surfaces To The Stenotic Material |